Development of an oral solid dispersion formulation for use in low-dose metronomic chemotherapy of paclitaxelMOES, Johannes; KOOLEN, Stijn; HUITEMA, Alwin et al.European journal of pharmaceutics and biopharmaceutics. 2013, Vol 83, Num 1, pp 87-94, issn 0939-6411, 8 p.Article

Oral Anticancer Drugs: Mechanisms of Low Bioavailability and Strategies for ImprovementSTUURMAN, Frederik E; NUIJEN, Bastiaan; BEIJNEN, Jos H et al.Clinical pharmacokinetics. 2013, Vol 52, Num 6, pp 399-414, issn 0312-5963, 16 p.Article

Photostability profiles of the experimental antimetastatic ruthenium complex NAMI-ABOUMA, Marjan; NUIJEN, Bastiaan; JANSEN, Martine T et al.Journal of pharmaceutical and biomedical analysis. 2002, Vol 30, Num 4, pp 1287-1296, issn 0731-7085, 10 p.Article

Development and validation of an LC-UV method for the quantification and purity determination of the novel anticancer agent C1311 and its pharmaceutical dosage formDEN BROK, Monique W. J; NUIJEN, Bastiaan; HILLEBRAND, Michel J. X et al.Journal of pharmaceutical and biomedical analysis. 2005, Vol 39, Num 1-2, pp 46-53, issn 0731-7085, 8 p.Article

Pharmaceutical heroin for inhalation : Thermal analysis and recovery experiments after volatilisationKLAUS, Marjolein G; BRONNER, Gaby M; NUIJEN, Bastiaan et al.Journal of pharmaceutical and biomedical analysis. 2005, Vol 39, Num 5, pp 944-950, issn 0731-7085, 7 p.Article

Pharmaceutical development of a lyophilised dosage form for the investigational anticancer agent imexon using dimethyl sulfoxide as solubilising and stabilising agentDEN BROK, Monique W. J; NUIJEN, Bastiaan; LUTZ, Christiane et al.Journal of pharmaceutical sciences. 2005, Vol 94, Num 5, pp 1101-1114, issn 0022-3549, 14 p.Article

Development and validation of a liquid chromatography-ultraviolet absorbance detection assay using derivatisation for the novel marine anticancer agent ES-285.HCl [(2S, 3R)-2-amino-3-octadecanol hydrochloride] and its pharmaceutical dosage formDEN BROK, Monique W. J; NUIJEN, Bastiaan; MIRANDA, Elena et al.Journal of chromatography. 2003, Vol 1020, Num 2, pp 251-258, issn 0021-9673, 8 p.Article

Compatibility and stability of the investigational polypeptide marine anticancer agent kahalalide F in infusion devicesNUIJEN, Bastiaan; BOUMA, Marjan; MANADA, Consuelo et al.Investigational new drugs. 2001, Vol 19, Num 4, pp 273-281, issn 0167-6997Article

Optimizing the therapeutic index of liposomal glucocorticoids in experimental arthritisVAN DEN HOVEN, Jolanda M; HOFKENS, Wouter; WAUBEN, Marca H. M et al.International journal of pharmaceutics (Print). 2011, Vol 416, Num 2, pp 471-477, issn 0378-5173, 7 p.Conference Paper

Lipopolysaccharide contamination in intradermal DNA vaccination: Toxic impurity or adjuvant?VAN DEN BERG, Joost H; QUAAK, Susanne G. L; BEIJNEN, Jos H et al.International journal of pharmaceutics (Print). 2010, Vol 390, Num 1, pp 32-36, issn 0378-5173, 5 p.Conference Paper

Process characterisation, optimisation and validation of production of diacetylmorphine/caffeine sachets: a design of experiments approachKLOUS, Marjolein G; NUIJEN, Bastiaan; VAN DEN BRINK, Wim et al.International journal of pharmaceutics. 2004, Vol 285, Num 1-2, pp 65-75, issn 0378-5173, 11 p.Article

A kinetic study of the chemical stability of the antimetastatic ruthenium complex NAMI-ABOUMA, Marjan; NUIJEN, Bastiaan; JANSEN, Martine T et al.International journal of pharmaceutics. 2002, Vol 248, Num 1-2, pp 239-246, issn 0378-5173, 8 p.Article

Progress in the development of alternative pharmaceutical formulations of taxanesNUIJEN, Bastiaan; BOUMA, Marjan; SCHELLENS, Jan H. M et al.Investigational new drugs. 2001, Vol 19, Num 2, pp 143-153, issn 0167-6997Article

LC-UV method development and validation for the investigational anticancer agent imexon and identification of its degradation productsDEN BROK, Monique W. J; NUIJEN, Bastiaan; HILLEBRAND, Michel J. X et al.Journal of pharmaceutical and biomedical analysis. 2005, Vol 38, Num 4, pp 686-694, issn 0731-7085, 9 p.Article

2-hydroxypropyl-β-cyclodextrin extracts 2-phenylphenol from silicone tubingDEN BROK, Monique W. J; VAN DER SCHOOT, Sabien C; NUIJEN, Bastiaan et al.International journal of pharmaceutics. 2004, Vol 278, Num 2, pp 303-309, issn 0378-5173, 7 p.Article

Development of a LC method for pharmaceutical quality control of the antimetastatic ruthenium complex NAMI-ABOUMA, Marjan; NUIJEN, Bastiaan; JANSEN, Martine T et al.Journal of pharmaceutical and biomedical analysis. 2003, Vol 31, Num 2, pp 215-228, issn 0731-7085, 14 p.Article

Shielding the cationic charge of nanoparticle-formulated dermal DNA vaccines is essential for antigen expression and immunogenicityVAN DEN BERG, Joost H; OOSTERHUIS, Koen; HENNINK, Wim E et al.Journal of controlled release. 2010, Vol 141, Num 2, pp 234-240, issn 0168-3659, 7 p.Article

Management of Hot Flashes in Patients Who Have Breast Cancer With Venlafaxine and Clonidine: A Randomized, Double-Blind, Placebo-Controlled TrialBOEKHOUT, Annelies H; VINCENT, Andrew D; DALESIO, Otilia B et al.Journal of clinical oncology. 2011, Vol 29, Num 29, pp 3862-3868, issn 0732-183X, 7 p.Article

Phase I clinical study with multiple peptide vaccines in combination with tetanus toxoid and GM-CSF in advanced-stage HLA-A*0201-positive melanoma patientsBINS, Adriaan; MALLO, Henk; SEIN, Johan et al.Journal of immunotherapy (1997). 2007, Vol 30, Num 2, pp 234-239, issn 1524-9557, 6 p.Article

Synthetic vehicles for DNA vaccinationVAN DEN BERG, Joost H; NUIJEN, Bastiaan; SCHUMACHER, Ton N et al.Journal of drug targeting. 2010, Vol 18, Num 1, pp 1-14, issn 1061-186X, 14 p.Article

Optimization of Intradermal Vaccination by DNA Tattooing in Human SkinVAN DEN BERG, Joost H; NUIJEN, Bastiaan; HAANEN, John B. A. G et al.Human gene therapy. 2009, Vol 20, Num 3, pp 181-189, issn 1043-0342, 9 p.Article